Literature DB >> 27799221

Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.

Laura Judith Marcos-Zambrano1,2, Pilar Escribano1,2, Carlos Sánchez-Carrillo1,2,3, Emilio Bouza1,2,3,4, Jesús Guinea5,2,3,4.   

Abstract

We report data on the frequency of the paradoxical effect of echinocandins against Candida spp. (n = 602 incident isolates) using the EUCAST definitive document EDef 7.2 procedure. The paradoxical effect for one or more echinocandins was observed in 16% of the isolates. However, differences between species were found, and the paradoxical effect was more common in Candida tropicalis (P < 0.001). Caspofungin was the drug in which the paradoxical effect was most common, followed by anidulafungin and micafungin (P < 0.001).
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  Candida; EUCAST; echinocandins; paradoxical effect

Mesh：

Substances：

Year:  2016        PMID： 27799221      PMCID： PMC5192150          DOI： 10.1128/AAC.01584-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

Authors:  Maiken C Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William Hope
Journal:  Clin Microbiol Infect       Date:  2012-05-08       Impact factor: 8.067

2.  Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Authors:  A Espinel-Ingroff; M C Arendrup; M A Pfaller; L X Bonfietti; B Bustamante; E Canton; E Chryssanthou; M Cuenca-Estrella; E Dannaoui; A Fothergill; J Fuller; P Gaustad; G M Gonzalez; J Guarro; C Lass-Flörl; S R Lockhart; J F Meis; C B Moore; L Ostrosky-Zeichner; T Pelaez; S R B S Pukinskas; G St-Germain; M W Szeszs; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

3.  In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms.

Authors:  Marisa H Miceli; Stella M Bernardo; Samuel A Lee
Journal:  Int J Antimicrob Agents       Date:  2009-08-11       Impact factor: 5.283

4.  Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum.

Authors:  Ryan K Shields; M Hong Nguyen; Chen Du; Ellen Press; Shaoji Cheng; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.

Authors:  Gregory A Eschenauer; M Hong Nguyen; Shmuel Shoham; Jose A Vazquez; Arthur J Morris; William A Pasculle; Christine J Kubin; Kenneth P Klinker; Peggy L Carver; Kimberly E Hanson; Sharon Chen; Simon W Lam; Brian A Potoski; Lloyd G Clarke; Ryan K Shields; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

Review 6.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

7.  Potential Microbiological Effects of Higher Dosing of Echinocandins.

Authors:  William J Steinbach; Frédéric Lamoth; Praveen R Juvvadi
Journal:  Clin Infect Dis       Date:  2015-12-01       Impact factor: 9.079

8.  Echinocandin Resistance in Candida.

Authors:  David S Perlin
Journal:  Clin Infect Dis       Date:  2015-12-01       Impact factor: 9.079

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

10.  Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

Authors:  M Fleischhacker; C Radecke; B Schulz; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-04       Impact factor: 3.267
View more
  5 in total

1.  Susceptibility and resistance of Sporothrix brasiliensis to branded and compounded itraconazole formulations.

Authors:  Stefanie Bressan Waller; Márcia Kutscher Ripoll; Isabel Martins Madrid; Tanize Acunha; Marlete Brum Cleff; Fábio Clasen Chaves; João Roberto Braga de Mello; Renata Osório de Faria; Mário Carlos Araújo Meireles
Journal:  Braz J Microbiol       Date:  2020-04-24       Impact factor: 2.476

2.  Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Laura Judith Marcos-Zambrano; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 3.  Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.

Authors:  Eric Dannaoui; Ana Espinel-Ingroff
Journal:  J Fungi (Basel)       Date:  2019-11-22

4.  Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.

Authors:  Zoltán Tóth; Lajos Forgács; Tamás Kardos; Renátó Kovács; Jeffrey B Locke; Gábor Kardos; Fruzsina Nagy; Andrew M Borman; Awid Adnan; László Majoros
Journal:  J Fungi (Basel)       Date:  2020-08-17

Review 5.  Recent Insights into the Paradoxical Effect of Echinocandins.

Authors:  Johannes Wagener; Veronika Loiko
Journal:  J Fungi (Basel)       Date:  2017-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.